Literature DB >> 14669529

Risk of recurrent intracerebral hemorrhages.

Ralf Buhl1, Harald Barth, Hubertus M Mehdorn.   

Abstract

Intracerebral hemorrhage (ICH) occurs in about 10%-15% of all strokes, and hypertension and cerebral amyloid angiopathy (CAA) are the main underlying causes. There is often controversy regarding surgical evacuation especially in elderly patients. Follow-up of these patients and regulation of hypertension is important to prevent re-bleeding. The number of recurrent hematomas will increase with time of follow-up. We reviewed 968 patients with an ICH treated in our Department and 48 patients with recurrent hemorrhages (4.9%). The mean interval between the first and the second hemorrhage was three years (one month to 10 years). Clinical outcome after a second hemorrhage was severe and only 50% of patients were operated on the second hemorrhage compared to 77% (37/48) of patients who were operated on the first hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669529     DOI: 10.1179/016164103771953952

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  4 in total

1.  The risk of recurrent stroke after intracerebral haemorrhage.

Authors:  H C Hanger; T J Wilkinson; N Fayez-Iskander; R Sainsbury
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-12       Impact factor: 10.154

Review 2.  Stroke Prevention After Intracerebral Hemorrhage: Where Are We Now?

Authors:  Hae Young Baang; Kevin N Sheth
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 2.931

3.  Treatment of 817 patients with spontaneous supratentorial intracerebral hemorrhage: characteristics, predictive factors and outcome.

Authors:  Homajoun Maslehaty; Athanasios K Petridis; Harald Barth; Alexandros Doukas; Hubertus Maximilian Mehdorn
Journal:  Clin Pract       Date:  2012-05-17

4.  Does statin increase the risk of intracerebral hemorrhage in stroke survivors? A meta-analysis and trial sequential analysis.

Authors:  Ru Jian Jonathan Teoh; Chi-Jung Huang; Chi Peng Chan; Li-Yin Chien; Chih-Ping Chung; Shih-Hsien Sung; Chen-Huan Chen; Chern-En Chiang; Hao-Min Cheng
Journal:  Ther Adv Neurol Disord       Date:  2019-07-24       Impact factor: 6.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.